These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 2589675)
1. Ancrod (Arvin) as an alternative to heparin anticoagulation for cardiopulmonary bypass. Zulys VJ; Teasdale SJ; Michel ER; Skala RA; Keating SE; Viger JR; Glynn MF Anesthesiology; 1989 Dec; 71(6):870-7. PubMed ID: 2589675 [TBL] [Abstract][Full Text] [Related]
2. Enoxaparin for unstable angina and ancrod for cardiac surgery following heparin allergy. Smith RE; Townsend GE; Berry BR; Bowen T Ann Pharmacother; 1996 May; 30(5):476-80. PubMed ID: 8740327 [TBL] [Abstract][Full Text] [Related]
3. Cardiopulmonary bypass with danaparoid sodium and ancrod in heparin-induced thrombocytopenia. Kanagasabay RR; Unsworth-White MJ; Robinson G; Bevan D; Farnsworth G; Haxby EJ; Smith EE Ann Thorac Surg; 1998 Aug; 66(2):567-9. PubMed ID: 9725413 [TBL] [Abstract][Full Text] [Related]
4. Ancrod anticoagulation for cardiopulmonary bypass in heparin-induced thrombocytopenia and thrombosis. Teasdale SJ; Zulys VJ; Mycyk T; Baird RJ; Glynn MF Ann Thorac Surg; 1989 Nov; 48(5):712-3. PubMed ID: 2818066 [TBL] [Abstract][Full Text] [Related]
14. Investigation of a thrombin inhibitor peptide as an alternative to heparin in cardiopulmonary bypass surgery. Chomiak PN; Walenga JM; Koza MJ; Reilly TM; Turlapathy P; Pifarre R Circulation; 1993 Nov; 88(5 Pt 2):II407-12. PubMed ID: 7993389 [TBL] [Abstract][Full Text] [Related]
15. Ancrod versus heparin for anticoagulation during vascular surgical procedures. Cole CW; Bormanis J; Luna GK; Hajjar G; Barber GG; Harris KA; Brien WF J Vasc Surg; 1993 Feb; 17(2):288-92; discussion 293. PubMed ID: 8433424 [TBL] [Abstract][Full Text] [Related]
16. A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION-ON study. Dyke CM; Smedira NG; Koster A; Aronson S; McCarthy HL; Kirshner R; Lincoff AM; Spiess BD J Thorac Cardiovasc Surg; 2006 Mar; 131(3):533-9. PubMed ID: 16515902 [TBL] [Abstract][Full Text] [Related]
17. Inactivated antithombin as anticoagulant reversal in a rat model of cardiopulmonary bypass: a potent and potentially safer alternative to protamine. Bianchini EP; Sebestyen A; Abache T; Bourti Y; Fontayne A; Richard V; Tamion F; Plantier JL; Doguet F; Borgel D Br J Haematol; 2018 Mar; 180(5):715-720. PubMed ID: 29363751 [TBL] [Abstract][Full Text] [Related]
18. An Adjusted Calculation Model of Reduced Heparin Doses in Cardiopulmonary Bypass Surgery in a Chinese Population. Zhang Y; Liu K; Li W; Xue Q; Hong J; Xu J; Wu L; Ji G; Sheng J; Wang Z J Cardiothorac Vasc Anesth; 2016 Oct; 30(5):1179-83. PubMed ID: 27475733 [TBL] [Abstract][Full Text] [Related]
19. Anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and renal impairment using heparin and the platelet glycoprotein IIb-IIIa antagonist tirofiban. Koster A; Kukucka M; Bach F; Meyer O; Fischer T; Mertzlufft F; Loebe M; Hetzer R; Kuppe H Anesthesiology; 2001 Feb; 94(2):245-51. PubMed ID: 11176088 [TBL] [Abstract][Full Text] [Related]
20. A randomized blind study comparing standard heparin and a new low molecular weight heparinoid in cardiopulmonary bypass surgery in dogs. Henny CP; Ten Cate H; Ten Cate JW; Moulijn AC; Sie TH; Warren P; Büller HR J Lab Clin Med; 1985 Aug; 106(2):187-96. PubMed ID: 4020247 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]